News

Even though thousands of clinical trials are listed on public websites, and sponsors are posting results from more key studies, consumer advocates continue to press for broader public disclosure of information on research involving human subjects.

Practical approaches to new challenges and opportunities in inflammation trials.

S

Regulators must stop approving so many new drugs of very limited therapeutic value, and the European Medicines Agency (EMA) and other regulatory bodies should be fully funded by public money rather than relying on industry-generated user fees, according to an article published by the British Medical Journal.

S

Illuminating the advantages of multiplexing for advanced biomarker testing.

Biomarkers help researchers develop new drugs faster and more effectively.

Industry news focusing on the people and organizations who work in the clinical trials profession.

eClinical: The Use of ePRO in Diabetes Studies CRO/Sponsor: Managing the Global Supply Chain Also in this issue: Clinical Trial Funding CRO Market Size Biosimilar Development